J Am Pharm Assoc (2003). 2021 Nov-Dec;61(6):709-714.e1. doi: 10.1016/j.japh.2021.05.009. Epub 2021 May 21.
Successful vaccination against coronavirus disease 2019 (COVID-19) is an essential component of achieving community immunity to bring the COVID-19 pandemic to an end. Vaccine hesitancy, identified as a top threat to global health by the World Health Organization, is a significant barrier to vaccine uptake. With COVID-19 vaccination programs in effect since December 2020, it is critical that vaccination barriers are proactively identified. With limited information surrounding college students' perspectives on COVID-19 vaccines, outreach measures will play a pivotal role in vaccine uptake in this population. Development of informative, cohort-driven vaccination campaigns requires proactive assessment of factors influencing vaccine hesitancy, access, and uptake.
The primary objective of this study was to investigate the spectrum of vaccine hesitancy among college students at the University of Rhode Island (URI). The secondary objective was to identify differences in COVID-19 and influenza vaccine hesitancy rates in this population.
A 22-item, Institutional Review Board-approved, anonymous questionnaire was developed to survey URI students who voluntarily attended 2 joint University Health Services and College of Pharmacy influenza vaccination clinics in November 2020.
A total of 237 vaccination clinic participants consented and responded to at least 1 question on the survey. Once available to their respective priority group, 92% are very/somewhat likely to receive a COVID-19 vaccine and 50% will receive a COVID-19 vaccine as soon as possible. Only 3% of the participants stated that they would never receive a COVID-19 vaccine. The top 3 reported COVID-19 vaccine-related concerns were safety (37%), effectiveness (24%), and limited information (16%). When asked if COVID-19 vaccines and influenza vaccines should be mandated, 85% and 83%, respectively, were in favor.
Understanding the spectrum of vaccine hesitancy is critical in achieving COVID-19 community immunity thresholds. URI students are willing to be vaccinated against COVID-19 provided that the vaccines are proven safe and efficacious.
成功接种 2019 年冠状病毒病（COVID-19）疫苗是实现社区免疫力以结束 COVID-19 大流行的重要组成部分。疫苗犹豫被世界卫生组织确定为对全球健康的最大威胁之一，是疫苗接种率的一个重大障碍。自 2020 年 12 月以来，COVID-19 疫苗接种计划已经生效，因此必须积极确定疫苗接种障碍。由于围绕大学生对 COVID-19 疫苗的看法的信息有限，因此在该人群中，推广措施将在疫苗接种方面发挥关键作用。制定信息丰富、针对特定群体的疫苗接种运动需要积极评估影响疫苗犹豫、获取和接种的因素。
本研究的主要目的是调查罗德岛大学（URI）大学生的疫苗犹豫程度。次要目的是确定该人群中 COVID-19 和流感疫苗犹豫率的差异。
开发了一个 22 项的、机构审查委员会批准的、匿名的调查问卷，以调查自愿参加 2020 年 11 月联合大学健康服务和药学院流感疫苗接种诊所的 URI 学生。
共有 237 名疫苗接种诊所参与者同意并回答了调查中的至少一个问题。一旦可以向他们各自的优先级群体提供疫苗，92%的人非常/有些可能会接种 COVID-19 疫苗，而 50%的人将尽快接种 COVID-19 疫苗。只有 3%的参与者表示他们永远不会接种 COVID-19 疫苗。报告的 COVID-19 疫苗相关担忧的前 3 位是安全性（37%）、有效性（24%）和信息有限（16%）。当被问及 COVID-19 疫苗和流感疫苗是否应该强制接种时，分别有 85%和 83%的人表示赞成。
了解疫苗犹豫的程度对于实现 COVID-19 社区免疫阈值至关重要。URI 学生愿意接种 COVID-19 疫苗，前提是疫苗被证明是安全有效的。
